CN102421416B - 包含丁卡因和血管收缩剂的用于鼻内给药的牙麻醉剂 - Google Patents

包含丁卡因和血管收缩剂的用于鼻内给药的牙麻醉剂 Download PDF

Info

Publication number
CN102421416B
CN102421416B CN201080020599.5A CN201080020599A CN102421416B CN 102421416 B CN102421416 B CN 102421416B CN 201080020599 A CN201080020599 A CN 201080020599A CN 102421416 B CN102421416 B CN 102421416B
Authority
CN
China
Prior art keywords
pharmaceutical composition
composition according
tissue
tetracaine
delivered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201080020599.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN102421416A (zh
Inventor
M·D·科拉尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ST RENATUS LLC
Original Assignee
ST RENATUS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ST RENATUS LLC filed Critical ST RENATUS LLC
Priority to CN201410169695.6A priority Critical patent/CN103932973B/zh
Publication of CN102421416A publication Critical patent/CN102421416A/zh
Application granted granted Critical
Publication of CN102421416B publication Critical patent/CN102421416B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M19/00—Local anaesthesia; Hypothermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201080020599.5A 2009-04-03 2010-04-02 包含丁卡因和血管收缩剂的用于鼻内给药的牙麻醉剂 Expired - Fee Related CN102421416B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410169695.6A CN103932973B (zh) 2009-04-03 2010-04-02 包含丁卡因和血管收缩剂的用于鼻内给药的牙麻醉剂

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16668009P 2009-04-03 2009-04-03
US61/166,680 2009-04-03
PCT/US2010/001002 WO2010114622A1 (en) 2009-04-03 2010-04-02 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201410169695.6A Division CN103932973B (zh) 2009-04-03 2010-04-02 包含丁卡因和血管收缩剂的用于鼻内给药的牙麻醉剂

Publications (2)

Publication Number Publication Date
CN102421416A CN102421416A (zh) 2012-04-18
CN102421416B true CN102421416B (zh) 2014-05-28

Family

ID=42164462

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201080020599.5A Expired - Fee Related CN102421416B (zh) 2009-04-03 2010-04-02 包含丁卡因和血管收缩剂的用于鼻内给药的牙麻醉剂
CN201410169695.6A Expired - Fee Related CN103932973B (zh) 2009-04-03 2010-04-02 包含丁卡因和血管收缩剂的用于鼻内给药的牙麻醉剂

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201410169695.6A Expired - Fee Related CN103932973B (zh) 2009-04-03 2010-04-02 包含丁卡因和血管收缩剂的用于鼻内给药的牙麻醉剂

Country Status (18)

Country Link
US (7) US8580282B2 (enExample)
EP (1) EP2413899B1 (enExample)
JP (3) JP5788864B2 (enExample)
KR (2) KR101747979B1 (enExample)
CN (2) CN102421416B (enExample)
AU (2) AU2010232995C1 (enExample)
BR (1) BRPI1010303A2 (enExample)
CA (1) CA2757032C (enExample)
DK (1) DK2413899T3 (enExample)
EA (1) EA024184B1 (enExample)
ES (1) ES2861064T3 (enExample)
IL (1) IL215489A0 (enExample)
MX (1) MX2011010445A (enExample)
NZ (2) NZ595376A (enExample)
PL (1) PL2413899T3 (enExample)
PT (1) PT2413899T (enExample)
WO (1) WO2010114622A1 (enExample)
ZA (2) ZA201107011B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5788864B2 (ja) 2009-04-03 2015-10-07 セイント レナタス， エルエルシー 鼻腔内投与用のテトラカインおよび血管収縮薬を含む歯科用麻酔剤
NZ629475A (en) 2012-09-28 2017-03-31 St Renatus Llc Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
WO2015103450A1 (en) * 2014-01-01 2015-07-09 Real Time Imaging Technologies, Llc Improved local anesthetic solution for dental and/or contrast media use
AU2015277272A1 (en) * 2014-06-16 2017-01-12 Loewi LLC Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
EA201791448A1 (ru) * 2014-12-23 2017-11-30 СТ. РЕНАТУС, ЭлЭлСи Анестетик на основе тетракаина
WO2016115117A1 (en) 2015-01-12 2016-07-21 Real Time Imaging Technologies, Llc Low-dose x-ray imaging system
US10039830B2 (en) * 2016-03-04 2018-08-07 Cetylite Industries, Inc. Topical anesthetic composition
WO2017210390A1 (en) * 2016-06-01 2017-12-07 St. Renatus, Llc Intranasal dental anesthetic
CA3122363A1 (en) 2018-12-19 2020-06-25 Nortic Holdings Inc. Therapeutic composition of intranasal lidocaine
CN111494310A (zh) * 2020-04-29 2020-08-07 周晓玲 一种局部麻醉药物的制备及使用方法
EP4648760A1 (en) * 2023-01-13 2025-11-19 Smilanich, Michael D. Composition for local anesthesia and uses thereof
GB2628149A (en) * 2023-03-16 2024-09-18 Lee Nathaniel Wurie Nasal spray for performing sphenopalatine ganglion block

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585398A (en) * 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
US6413499B1 (en) * 2000-01-06 2002-07-02 Bryan M. Clay Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832460A (en) * 1971-03-19 1974-08-27 C Kosti Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
US5209724A (en) 1988-04-11 1993-05-11 Dhaliwal Avtar S Composite anesthetic article and method of use
AU4673993A (en) 1992-07-28 1994-02-14 Procter & Gamble Company, The Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
US5854269A (en) 1993-11-19 1998-12-29 Schering-Plough Healthcare Products, Inc. Nasal spray compositions
US6075059A (en) 1999-02-24 2000-06-13 The Ohio State University Compositions for dental anesthesia
US20040131665A1 (en) * 1999-10-22 2004-07-08 Wepfer Scott T. Topical anesthetic formulation
US20040045546A1 (en) 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
JP4591746B2 (ja) * 2002-12-03 2010-12-01 大正製薬株式会社 難溶性抗ウイルス成分含有水溶性外用剤組成物
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
WO2005065696A1 (en) 2004-01-01 2005-07-21 Panacea Biotec Ltd. Pharmaceutical compositions comprising an extract of euphorbia prostrata
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
WO2007050543A2 (en) 2005-10-24 2007-05-03 Collegium Pharmaceutical, Inc. Topical pharmaceutical foam composition
US9252862B2 (en) 2008-09-17 2016-02-02 Qualcomm Incorporated MIMO preamble for initial access with an unknown number of transmit antennas
JP5788864B2 (ja) * 2009-04-03 2015-10-07 セイント レナタス， エルエルシー 鼻腔内投与用のテトラカインおよび血管収縮薬を含む歯科用麻酔剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585398A (en) * 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
US6413499B1 (en) * 2000-01-06 2002-07-02 Bryan M. Clay Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic

Also Published As

Publication number Publication date
AU2015242984B2 (en) 2017-09-14
AU2010232995C1 (en) 2016-01-28
EA201171215A1 (ru) 2012-07-30
AU2010232995A1 (en) 2011-10-20
US10420750B2 (en) 2019-09-24
US20170326112A1 (en) 2017-11-16
CA2757032C (en) 2022-06-07
US20170326111A1 (en) 2017-11-16
IL215489A0 (en) 2011-12-29
JP2015034167A (ja) 2015-02-19
CN102421416A (zh) 2012-04-18
KR20120042729A (ko) 2012-05-03
US20170319547A1 (en) 2017-11-09
US20160184269A1 (en) 2016-06-30
US9308191B2 (en) 2016-04-12
JP5788864B2 (ja) 2015-10-07
US20140234421A1 (en) 2014-08-21
KR20170026639A (ko) 2017-03-08
CN103932973B (zh) 2017-08-11
NZ595376A (en) 2013-09-27
AU2010232995B2 (en) 2015-07-16
PL2413899T3 (pl) 2021-09-20
BRPI1010303A2 (pt) 2016-03-15
EA024184B1 (ru) 2016-08-31
KR101747979B1 (ko) 2017-06-15
CN103932973A (zh) 2014-07-23
CA2757032A1 (en) 2010-10-07
US10456377B2 (en) 2019-10-29
ZA201107011B (en) 2014-03-26
EP2413899B1 (en) 2021-01-27
US20120039960A1 (en) 2012-02-16
JP2012522783A (ja) 2012-09-27
NZ612063A (en) 2015-02-27
WO2010114622A1 (en) 2010-10-07
ZA201309321B (en) 2016-07-27
DK2413899T3 (da) 2021-04-19
AU2015242984A1 (en) 2015-11-05
PT2413899T (pt) 2021-03-30
US8580282B2 (en) 2013-11-12
US20200268715A1 (en) 2020-08-27
MX2011010445A (es) 2012-01-19
JP2017031226A (ja) 2017-02-09
US9855247B2 (en) 2018-01-02
ES2861064T3 (es) 2021-10-05
EP2413899A1 (en) 2012-02-08

Similar Documents

Publication Publication Date Title
CN102421416B (zh) 包含丁卡因和血管收缩剂的用于鼻内给药的牙麻醉剂
CN107249568A (zh) 基于丁卡因的麻醉药
US20240238224A1 (en) Composition for local anaesthesia and uses thereof
HK1165296B (en) Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
US20170360718A1 (en) Intranasal dental anesthetic

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140528